Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1,92%
1 092,74
-21,40
-1,92%
1 114,141 119,391 121,191 092,22
SIXC
Communications
SIXC
Communications
SIXC
-0,04%
613,36
-0,24
-0,04%
613,60613,60617,80611,65
SIXE
Energy
SIXE
Energy
SIXE
-1,82%
1 176,79
-21,77
-1,82%
1 198,561 188,461 188,461 159,56
SIXI
Industrials
SIXI
Industrials
SIXI
-1,62%
1 755,54
-28,91
-1,62%
1 784,451 788,951 792,831 749,89
SIXM
Financials
SIXM
Financials
SIXM
-0,57%
635,15
-3,64
-0,57%
638,79638,37641,72633,76
SIXR
Staples
SIXR
Staples
SIXR
-0,29%
848,01
-2,49
-0,29%
850,50848,90851,07839,52
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,83%
217,86
-1,83
-0,83%
219,69219,69219,69216,89
SIXT
Technology
SIXT
Technology
SIXT
-0,20%
3 417,35
-6,84
-0,20%
3 424,193 429,183 463,333 398,08
SIXU
Utilities
SIXU
Utilities
SIXU
-1,34%
913,36
-12,40
-1,34%
925,76922,77923,99911,22
SIXV
Health care
SIXV
Health care
SIXV
-0,48%
1 462,38
-7,02
-0,48%
1 469,401 468,961 473,181 457,86
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,06%
2 423,14
-1,48
-0,06%
2 424,622 438,232 446,632 412,48
Q1 2026 earnings • released • EPS miss -17,38% • Revenue miss -1,99%
See results
UTHR:NASDAQ
United Therapeutics Corp
569,18 $
-4,62%
(-27,58) 1D
569,18 $
0,00% (0,00)
After hours
Closed: 7 մյս, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for UTHR...
Open
599,00 $
High
599,00 $
Low
568,75 $
Mkt. cap
24,15 մլրդ
Avg. vol.
547,65 հզր
Volume
830,89 հզր
P/E ratio
20,43
52-wk high
609,35 $
52-wk low
272,18 $
EPS
27,86 $
Beta
0,60
Shares outstanding
43,83 մլն
No. of employees
1 հզր
News stories
From sources across the web
Profile
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
About United Therapeutics Corp
CEO-
Employees1,4 հզր
Founded1996
HeadquartersՍիլվեր Սփրինգ, Մերիլենդ, Միացյալ Նահանգներ
Sector-
Last report
06 մյս, 2026 թ.
Fiscal Period
Q1 2026
EPS / Est. (USD)
5,82 $ / 7,04 $
-17,38%miss
Revenue / Est. (USD)
781,50 մլն / 797,38 մլն
-1,99%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. մրտ
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
Revenue
794,40 մլն
798,60 մլն
799,50 մլն
790,20 մլն
Cost of goods sold
92,50 մլն
87,60 մլն
100,90 մլն
103,40 մլն
Cost of revenue
92,50 մլն
87,60 մլն
100,90 մլն
103,40 մլն
Research and development expenses
149,00 մլն
134,00 մլն
127,50 մլն
139,50 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
170,10 մլն
190,80 մլն
181,80 մլն
189,90 մլն
Operating expense
319,10 մլն
324,80 մլն
309,30 մլն
329,40 մլն
Total operating expenses
411,60 մլն
412,40 մլն
410,20 մլն
432,80 մլն
Operating income
382,80 մլն
386,20 մլն
389,30 մլն
357,40 մլն
Other non operating income
1,00 մլն
3,90 մլն
300,00 հզր
800,00 հզր
EBT including unusual items
423,50 մլն
408,40 մլն
438,00 մլն
444,00 մլն
EBT excluding unusual items
428,80 մլն
434,10 մլն
433,00 մլն
398,30 մլն
Income tax expense
101,30 մլն
98,90 մլն
99,30 մլն
79,70 մլն
Effective tax rate
23,92%
24,22%
22,67%
17,95%
Other operating expenses
-
-
-
-
Net income
322,20 մլն
309,50 մլն
338,70 մլն
364,30 մլն
Net profit margin
40,56%
38,76%
42,36%
46,10%
Earnings per share
6,63
6,41
7,16
7,70
Interest and investment income
51,10 մլն
51,30 մլն
46,40 մլն
43,20 մլն
Interest expense
-6,10 մլն
-7,30 մլն
-3,00 մլն
-3,10 մլն
Net interest expenses
45,00 մլն
44,00 մլն
43,40 մլն
40,10 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
402,60 մլն
407,30 մլն
411,20 մլն
380,20 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more